Want to know more about IFI or contribute to this hub?

Please contact:

If you have a question or you would like to receive information, please complete the form. By sending information by means of this form, you agree that the information provided by you is governed by the provisions of the Privacy Policy of our site.

For all your medical questions, please send an e-mail to

Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting schemes: for the Netherlands. Adverse reactions may also be reported directly to the manufacturer of the suspected product. Adverse reactions related to Gilead products may be reported directly to Gilead via email:

Our office is located in Amsterdam.

Gilead Sciences
Viñoly Tower, Claude Debussylaan 22
1082 MD Amsterdam

All fields with a * are mandatory